Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, today announced the voting ...
Investor Demand Increases Previously Announced Proceeds by $100,000Toronto, Ontario--(Newsfile Corp. - September 25, 2025) - ...
Sentiment within the industry remains subdued. The Crypto Fear and Greed Index sits at 45, which is neutral, but leaning ...
Free Malaysia Today on MSN
Dollar gains against peers after US economic data
The dollar gained against peers including the euro and yen on Thursday on news that the U.S. economy grew faster than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback